Timo ten Hagen
Timo ten Hagen
Unknown affiliation
Verified email at erasmusmc.nl
Cited by
Cited by
TNF‐α in cancer treatment: molecular insights, antitumor effects, and clinical utility
R van Horssen, TLM Ten Hagen, AMM Eggermont
The oncologist 11 (4), 397-408, 2006
Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin
RM Schiffelers, GA Koning, TLM ten Hagen, MHAM Fens, AJ Schraa, ...
Journal of Controlled Release 91 (1-2), 115-122, 2003
Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors
AA Manzoor, LH Lindner, CD Landon, JY Park, AJ Simnick, MR Dreher, ...
Cancer research 72 (21), 5566-5575, 2012
Current uses of isolated limb perfusion in the clinic and a model system for new strategies
AMM Eggermont, JHW de Wilt, TLM ten Hagen
The lancet oncology 4 (7), 429-437, 2003
Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines
A Hollestelle, JHA Nagel, M Smid, S Lam, F Elstrodt, M Wasielewski, ...
Breast cancer research and treatment 121 (1), 53-64, 2010
Hyperthermia and thermosensitive liposomes for improved delivery of chemotherapeutic drugs to solid tumors
GA Koning, AMM Eggermont, LH Lindner, TLM ten Hagen
Pharmaceutical research 27 (8), 1750-1754, 2010
Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibition
PM Krawczyk, B Eppink, J Essers, J Stap, H Rodermond, H Odijk, ...
Proceedings of the National Academy of Sciences 108 (24), 9851-9856, 2011
In vivo micro particle image velocimetry measurements of blood-plasma in the embryonic avian heart
P Vennemann, KT Kiger, R Lindken, BCW Groenendijk, ...
Journal of biomechanics 39 (7), 1191-1200, 2006
Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion
JHW De Wilt, TLM ten Hagen, G De Boeck, ST Van Tiel, EA De Bruijn, ...
British journal of cancer 82 (5), 1000-1003, 2000
Triggered content release from optimized stealth thermosensitive liposomes using mild hyperthermia
L Li, TLM ten Hagen, D Schipper, TM Wijnberg, GC van Rhoon, ...
Journal of Controlled Release 143 (2), 274-279, 2010
Macrophages eliminate circulating tumor cells after monoclonal antibody therapy
N Gül, L Babes, K Siegmund, R Korthouwer, M Bögels, R Braster, ...
The Journal of clinical investigation 124 (2), 812-823, 2014
Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy
L Li, TLM ten Hagen, M Hossann, R Süss, GC van Rhoon, ...
Journal of Controlled Release 168 (2), 142-150, 2013
Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate–containing RGD peptide liposomes inhibits experimental arthritis
GA Koning, RM Schiffelers, MHM Wauben, RJ Kok, E Mastrobattista, ...
Arthritis & Rheumatism 54 (4), 1198-1208, 2006
TNF-α augments intratumoural concentrations of doxorubicin in TNF-α-based isolated limb perfusion in rat sarcoma models and enhances anti-tumour effects
AH van der Veen, JHW de Wilt, AMM Eggermont, ST van Tiel, ...
British journal of cancer 82 (4), 973-980, 2000
Tumor necrosis factor α mediates homogeneous distribution of liposomes in murine melanoma that contributes to a better tumor response
ALB Seynhaeve, S Hoving, D Schipper, CE Vermeulen, ...
Cancer research 67 (19), 9455-9462, 2007
Role of CLASP2 in microtubule stabilization and the regulation of persistent motility
K Drabek, M van Ham, T Stepanova, K Draegestein, R van Horssen, ...
Current Biology 16 (22), 2259-2264, 2006
Improved intratumoral nanoparticle extravasation and penetration by mild hyperthermia
L Li, TLM ten Hagen, M Bolkestein, A Gasselhuber, J Yatvin, ...
Journal of Controlled Release 167 (2), 130-137, 2013
Cell membrane modulation as adjuvant in cancer therapy
S Zalba, TLM Ten Hagen
Cancer treatment reviews 52, 48-57, 2017
Peptide-targeted PEG-liposomes in anti-angiogenic therapy
A Janssen, RM Schiffelers, TLM Ten Hagen, GA Koning, AJ Schraa, ...
International journal of pharmaceutics 254 (1), 55-58, 2003
Prerequisites for effective isolated limb perfusion using tumour necrosis factor alpha and melphalan in rats
JHW De Wilt, ER Manusama, ST Van Tiel, MGA Van Ijken, ...
British journal of cancer 80 (1), 161-166, 1999
The system can't perform the operation now. Try again later.
Articles 1–20